Pedro Renato de Paula Brandão

Brasilia Parkinson Cohort: assessing clinical, neuropsychological and imaging predictors of cognitive decline in Parkinson's disease

M. Tavares, T. Grippe, F. Cardoso, 2019 .

Leading RNA Interference Therapeutics Part 2: Silencing Delta-Aminolevulinic Acid Synthase 1, with a Focus on Givosiran

R. Titze-de-Almeida, Pedro Renato de Paula Brandão, Simoneide S Titze-de-Almeida, 2019, Molecular Diagnosis & Therapy.

microRNA signatures in prodromal REM sleep behavior disorder and early Parkinson's disease as noninvasive biomarkers.

W. Oertel, C. Schenck, R. Titze-de-Almeida, 2021, Sleep medicine.

Persistent, new-onset symptoms and mental health complaints in Long COVID in a Brazilian cohort of non-hospitalized patients

H. Shimizu, R. Titze-de-Almeida, Pedro Renato de Paula Brandão, 2022, BMC Infectious Diseases.

Leading RNA Interference Therapeutics Part 2: Silencing Delta-Aminolevulinic Acid Synthase 1, with a Focus on Givosiran

R. Titze-de-Almeida, Pedro Renato de Paula Brandão, Simoneide S Titze-de-Almeida, 2019, Molecular Diagnosis & Therapy.